Health

Rep. Jamie Raskin (D-Md.) expressed his opinion that Dr. Anthony Fauci is not a comic book super-villain amidst the House subcommittee investigation on COVID-19’s origins. This highlights the challenges faced by healthcare professionals during the pandemic. Dr. Jason Liebowitz from Columbia University shared his experience of feeling replaceable in the eyes of his employer after
0 Comments
Tirzepatide, a weight loss and diabetes drug, has shown promising results in treating Metabolic Dysfunction Associated Steatohepatitis (MASH) in a phase II study called SYNERGY-NASH. The study, presented by Dr. Rohit Loomba at the European Association for the Study of the Liver annual meeting, demonstrated significant resolution of MASH and liver fibrosis in participants receiving
0 Comments
The search for Michael Mosley, MD, a British weight-loss doctor and television personality who went missing while vacationing on the island of Symi, has caused growing concern among authorities and the public. The uncertainty surrounding his disappearance raises questions about his safety and well-being. In a worrying development, cows infected with bird flu have been
0 Comments
Central sleep apnea is a serious condition that affects many patients with heart failure, leading to interrupted signals from the brain to the body and causing breathing difficulties during sleep. The use of transvenous phrenic nerve stimulation (TPNS) has been associated with a significant improvement in clinical outcomes for these patients, according to a recent
0 Comments
Recently, a concerning incident occurred where numerous passengers on a flight to Houston fell ill with an unknown illness after returning from an international cruise. This raises questions about the potential spread of infectious diseases through air travel and highlights the importance of stringent health protocols in such situations. Dr. Anthony Fauci, a key figure
0 Comments
A recent interim analysis of the phase III ECHELON-3 trial revealed that a triplet combination of brentuximab vedotin (BV), lenalidomide, and rituximab showed a significant improvement in overall survival for patients with diffuse large B-cell lymphoma (DLBCL). The study, conducted by Jeong-A Kim, MD, at the American Society of Clinical Oncology meeting, demonstrated a 37%
0 Comments